HuagongsheHuagongshe Chemistry Print Report · For research reference only
Doxorubicin Hydrochloride → HCID 131727237, compound
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Doxorubicin Hydrochloride | HCID 443939 | — |
| Reactant | Potassium 1,2,3,6-tetrahydro-2,6-dioxopyrimidine-4-carboxylate | HCID 23665705 | — |
| Solvent | Water | HCID 962 | — |
| Product | HCID 131727237 | HCID 131727237 | 112.1% |
Reaction Steps
Potassium orotate (0.4 g) synthesized in the above step was dissolved in 150 mL of water at 65° C. The solution was de-aired in vacuum and protected with argon. Doxorubicin hydrochloride (1.0 g, 1 eq) was added and the resulting red solution was treated with excess amount of amberlite IR120H resin for 2 hours at the same temperature. After filtration the solution was frozen in dry ice, and lyophilized to give 1.35 g of doxorubicin orotate (J-1220-13-II) as a red solid. Mass Spectroscopy (FIG. 3) and Nuclear Magnetic Resonance (FIG. 4) indicate that the structure is doxorubicin orotate.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08148339B2 |
| Source dataset | uspto-grants-2012_04 |
| ORD ID | ord-491d3ceb879b4181a7c36d56f5e75129 |
| Source note | uspto-grants-2012_04 |